Cargando…

Multiple sclerosis: Possible immunological mechanisms()

Multiple sclerosis is the principal demyelinating disease of the central nervous system. Although the prevalence of the disease is moderately low, averaging about 40 cases per 100,000 people in high risk areas, it is a particularly devastating disease. It primarily affects young adults, is chronic,...

Descripción completa

Detalles Bibliográficos
Autores principales: McFarland, Henry F., Dhib-Jalbut, Suhayl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133204/
https://www.ncbi.nlm.nih.gov/pubmed/2521315
http://dx.doi.org/10.1016/0090-1229(89)90116-5
_version_ 1783517580358582272
author McFarland, Henry F.
Dhib-Jalbut, Suhayl
author_facet McFarland, Henry F.
Dhib-Jalbut, Suhayl
author_sort McFarland, Henry F.
collection PubMed
description Multiple sclerosis is the principal demyelinating disease of the central nervous system. Although the prevalence of the disease is moderately low, averaging about 40 cases per 100,000 people in high risk areas, it is a particularly devastating disease. It primarily affects young adults, is chronic, and has an unpredictable course. Most discouraging, the cause of the disease is not known and an effective treatment has not been identified. Recently, however, research has yielded some important findings concerning the etiology of MS. Much evidence now points to an immunological process as one of the major elements in the disease. It is also likely that an environmental influence, possibly an infectious process, may contribute to the disease. Finally, it is now certain that genetic makeup influences susceptibility to the disease. At present, the strongest evidence is for a polygenic effect, not the effect of a single gene or gene locus. This review will examine some of the possible immunologically mediated disease processes that could be involved in MS, especially those that could account for a role for infectious and genetic factors in the disease.
format Online
Article
Text
id pubmed-7133204
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71332042020-04-08 Multiple sclerosis: Possible immunological mechanisms() McFarland, Henry F. Dhib-Jalbut, Suhayl Clin Immunol Immunopathol Article Multiple sclerosis is the principal demyelinating disease of the central nervous system. Although the prevalence of the disease is moderately low, averaging about 40 cases per 100,000 people in high risk areas, it is a particularly devastating disease. It primarily affects young adults, is chronic, and has an unpredictable course. Most discouraging, the cause of the disease is not known and an effective treatment has not been identified. Recently, however, research has yielded some important findings concerning the etiology of MS. Much evidence now points to an immunological process as one of the major elements in the disease. It is also likely that an environmental influence, possibly an infectious process, may contribute to the disease. Finally, it is now certain that genetic makeup influences susceptibility to the disease. At present, the strongest evidence is for a polygenic effect, not the effect of a single gene or gene locus. This review will examine some of the possible immunologically mediated disease processes that could be involved in MS, especially those that could account for a role for infectious and genetic factors in the disease. Published by Elsevier Inc. 1989-01 2004-02-04 /pmc/articles/PMC7133204/ /pubmed/2521315 http://dx.doi.org/10.1016/0090-1229(89)90116-5 Text en Copyright © 1989 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
McFarland, Henry F.
Dhib-Jalbut, Suhayl
Multiple sclerosis: Possible immunological mechanisms()
title Multiple sclerosis: Possible immunological mechanisms()
title_full Multiple sclerosis: Possible immunological mechanisms()
title_fullStr Multiple sclerosis: Possible immunological mechanisms()
title_full_unstemmed Multiple sclerosis: Possible immunological mechanisms()
title_short Multiple sclerosis: Possible immunological mechanisms()
title_sort multiple sclerosis: possible immunological mechanisms()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133204/
https://www.ncbi.nlm.nih.gov/pubmed/2521315
http://dx.doi.org/10.1016/0090-1229(89)90116-5
work_keys_str_mv AT mcfarlandhenryf multiplesclerosispossibleimmunologicalmechanisms
AT dhibjalbutsuhayl multiplesclerosispossibleimmunologicalmechanisms